Open AccessBurden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study
Author(s) -
Vinod Kumar,
Malay Ranjan Sen,
Chaitanya Nigam,
Rupam Gahlot,
Shweta Kumari
Publication year - 2012
Publication title -
indian journal of critical care medicine/indian journal of critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 30
eISSN - 1998-359X
pISSN - 0972-5229
DOI - 10.4103/0972-5229.102077
Subject(s) - pseudomonas aeruginosa , microbiology and biotechnology , cephalosporin , imipenem , piperacillin , antibiotics , beta lactamase , medicine , multiple drug resistance , antibiotic resistance , antimicrobial , biology , bacteria , gene , biochemistry , genetics , escherichia coli
Pseudomonas aeruginosa is one of the most common pathogens causing infections in burns, and shows increasing resistance to β-lactam antibiotics by producing different classes of beta-lactamases. It is also not unusual to find a single isolate that expresses multiple β-lactamase enzymes, further complicating the treatment options. Thus, in this study, we aimed to determine the coexistence of different beta-lactamase enzymes in clinical isolates of P. aeruginosa in the burn ward.